Research Type: Extramural
Using high resolution molecular profiling technology, Associate Professor Gallego Ortega and his team have been studying MDSCs – trying to understand how they work, so they can develop treatments that block these cells.
In this project, Professor Lock and his team will investigate lncRNAs specifically in childhood AML.
Associate Professor Marina Pajic and her team have identified a molecular pathway that controls communication between pancreatic cancer cells and stromal cells.
Dr Seong Beom Ahn and team’s research aims to change CRC patient clinical management, by being able to provide certainty, clinicians will make better-informed treatment decisions.
Dr Klaartje Somers from Children’s Cancer Institute and Dr Deborah Meyran from Peter MacCallum Cancer Centre, along with their teams, are investigating ways to overcome the challenges of treating solid tumours with CAR T-cell immunotherapy
Recent research has found that androgens (such as testosterone) can activate an important anti-cancer immune response in prostate cancer cells.
Professor Kavallaris and her team aim to dramatically reduce duration of tumour testing programs, with direct benefits to patients from more rapid adoption of recommended treatments.
A/Professor Croucher and his team are investigating new treatment options for triple-negative breast cancers that have spread.
Dr Wang will investigate and detail how leukaemic stem cells are able to survive and renew.